China SXT Pharmaceuticals (SXTC) Short term Debt (2018 - 2025)
Historic Short term Debt for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $4475.0.
- China SXT Pharmaceuticals' Short term Debt fell 9993.99% to $4475.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4475.0, marking a year-over-year decrease of 9993.99%. This contributed to the annual value of $8781.0 for FY2025, which is 9821.91% down from last year.
- China SXT Pharmaceuticals' Short term Debt amounted to $4475.0 in Q3 2025, which was down 9993.99% from $8781.0 recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Short term Debt ranged from a high of $12.1 million in Q1 2021 and a low of $4475.0 during Q3 2025
- Moreover, its 5-year median value for Short term Debt was $849580.5 (2022), whereas its average is $2.6 million.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Short term Debt skyrocketed by 452781.21% in 2021, and later tumbled by 9993.99% in 2025.
- Quarter analysis of 5 years shows China SXT Pharmaceuticals' Short term Debt stood at $2.1 million in 2021, then plummeted by 43.04% to $1.2 million in 2022, then skyrocketed by 106.96% to $2.5 million in 2023, then skyrocketed by 198.34% to $7.4 million in 2024, then crashed by 99.94% to $4475.0 in 2025.
- Its Short term Debt was $4475.0 in Q3 2025, compared to $8781.0 in Q1 2025 and $7.4 million in Q3 2024.